Dr. Prakash Varadarajan, MD
- Medicare services, 2024
- 1,458
- Medicare patients, 2024
- 233
- Part D claims, 2024
- 1,577
- Publications
- 3
- Clinical trials
- 1
- Practice address
- 825 Eastlake Avenue East, Seattle, WA 98109
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Varadarajan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Prakash Varadarajan is a hematologist and oncologist in Seattle, Washington
Dr. Varadarajan practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.
Dr. Varadarajan's NPI, 1134364516, was assigned on December 12, 2008. Dr. Varadarajan holds Washington license MD60614514.
- NPI
- 1134364516NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9537325089
- NPI enumeration date
- December 12, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Prakash Varadarajan practices at Fred Hutchinson Cancer Center in Seattle, Washington
Dr. Varadarajan's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.
- Fred Hutchinson Cancer Center825 Eastlake Avenue East, Seattle, WA 98109
Source: Dmand AI Affiliation Data
Dr. Prakash Varadarajan is affiliated with 4 sites of care and 1 medical group
Dr. Varadarajan's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Varadarajan is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Dr. Varadarajan to 2 more hospitals, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Prakash Varadarajan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varadarajan practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Fred Hutchinson Cancer Center | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Fred Hutchinson Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Prakash Varadarajan is one of 348 hematologists and oncologists in Washington
Hematology and oncology is Dr. Varadarajan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Varadarajan is licensed in Washington.
Specialties and state licenses
- Hematology and oncology, WashingtonPrimary
Hematologists and oncologists near Dr. Varadarajan
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Prakash Varadarajan billed Medicare for 1,458 services in 2024
CMS data shows 1,458 Medicare services from Dr. Varadarajan across 11 procedure codes in 2024, for 233 Medicare patients. Medicare paid $95,067 for them.
Dr. Varadarajan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8372024: 837No change
- Other services
- 2023: 312024: 6211903%
Where Dr. Varadarajan's Medicare services took place, 2024
- In an office1,36594%
- In a facility936%
Dr. Varadarajan compared with the Washington median for hematologists and oncologists, 2024
- Dr. Varadarajan
- Washington median
- Medicare services
- 1,458vs 5852.5 times
- Medicare patients
- 233vs 18228% above
- Part D claims
- 1,214vs 2834.3 times
Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Varadarajan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Varadarajan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Varadarajan and other hematologists and oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Prakash Varadarajan treated 233 Medicare patients in 2024, average age 75
CMS counts 233 Medicare patients who saw Dr. Varadarajan in 2024. The largest group is 65 to 74, with 103 patients. 70% of them have high blood pressure, and 65% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Varadarajan's median patient age at 70, with 41% women.
Dr. Varadarajan's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Varadarajan's Medicare patients by sex, 2024
- Women9340%
- Men14060%
Chronic conditions among Dr. Varadarajan's Medicare patients, 2024
- High blood pressure70%
- High cholesterol65%
- Cancer44%
- Arthritis39%
- Ischemic heart disease32%
- Chronic kidney disease27%
- Diabetes25%
- Atrial fibrillation24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Varadarajan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women41%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Prakash Varadarajan wrote 1,577 Medicare Part D claims in 2024
In 2024, Dr. Varadarajan wrote 1,577 Medicare Part D claims for 195 patients. 78% of them were for generic drugs. CMS names the drug for 1,214 of them, across 41 drugs with 11 or more claims each, at $4,229,130 in total drug cost. In 2023, CMS named 1,187 claims across 39 drugs.
Dr. Varadarajan's Part D claims by kind of drug, 2024
- Generic1,227 claims78%
- Brand-name and other350 claims22%
Dr. Varadarajan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Varadarajan's Part D claims, 2024
- Opioids4%66 of 1,577 claims
- Antibiotics2%26 of 1,577 claims
- Antipsychotics, patients 65 and over1%21 of 1,577 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1872024: 1,2142%
Drugs named by CMS: 41 in 2024, 39 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Prakash Varadarajan scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Varadarajan for performance year 2024, reported through an alternative payment model (APM). Dr. Varadarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Varadarajan as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Varadarajan's MIPS scores, performance year 2024
- 94of 100Final score
- 74.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Prakash Varadarajan has 3 publications on record
Dmand AI links 3 papers to Dr. Varadarajan, published from 2011 to 2016. Dr. Varadarajan's most frequent co-authors are Athanassios Argiris, MD, Ralph J. Deberardinis, MD, PhD and Yissela Analy Escobedo.
Dr. Varadarajan's papers by year, 2011 to 2016
Dr. Varadarajan's most frequent co-authors
- Athanassios Argiris, MD1 shared paper
- Ralph J. Deberardinis, MD, PhD1 shared paper
- Yissela Analy Escobedo1 shared paper
Recent publications by Dr. Varadarajan
See who Dr. Varadarajan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Varadarajan works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Prakash Varadarajan has worked on 1 clinical trial
Dmand AI links Dr. Varadarajan to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.
Conditions in Dr. Varadarajan's trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Varadarajan
Recent clinical trials with Dr. Varadarajan
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Prakash Varadarajan received $2,039 in industry payments from 2016 to 2021
CMS Open Payments shows 132 general payments to Dr. Varadarajan from 26 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $442.
General payments to Dr. Varadarajan by program year, 2016 to 2021
General payments to Dr. Varadarajan by kind, 2016 to 2021
- Food and beverage$2,00898%
- Education$312%
Companies that paid Dr. Varadarajan the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Prakash Varadarajan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Prakash Varadarajan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Prakash Varadarajan's NPI number?
Dr. Prakash Varadarajan's NPI number is 1134364516. It was assigned on December 12, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Prakash Varadarajan?
Dr. Prakash Varadarajan is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Prakash Varadarajan practice?
Dr. Varadarajan practices at 825 Eastlake Avenue East, Seattle, WA 98109. Dr. Varadarajan's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dmand AI also links Dr. Varadarajan to 2 hospitals.
What is Dr. Prakash Varadarajan's medical license number?
Dr. Varadarajan holds Washington license MD60614514.
Which hospitals is Dr. Prakash Varadarajan affiliated with?
Dr. Varadarajan practices at Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Varadarajan is also affiliated with UW Medical Center - Montlake. Dmand AI links Dr. Varadarajan to 2 more hospitals.
What medical group is Dr. Prakash Varadarajan part of?
Dr. Varadarajan is linked to UW Physicians.
Does Dr. Prakash Varadarajan accept Medicare?
Yes. CMS data shows Dr. Varadarajan billed Medicare for 1,458 services in 2024, and Dr. Varadarajan accepts Medicare assignment.
Does Dr. Prakash Varadarajan offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Varadarajan as offering telehealth services.
What is Dr. Prakash Varadarajan's MIPS score?
Dr. Varadarajan's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Prakash Varadarajan see?
CMS counts 233 Medicare patients who saw Dr. Varadarajan in 2024, with an average age of 75.
Show 6 more questionsShow fewer questions
What services does Dr. Prakash Varadarajan bill to Medicare?
In 2024, Dr. Varadarajan's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).
What drugs does Dr. Prakash Varadarajan prescribe most?
In 2024 Medicare Part D data, Dr. Varadarajan's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Ondansetron HCl.
Has Dr. Prakash Varadarajan received payments from drug or device companies?
CMS Open Payments shows $2,039 in general payments to Dr. Varadarajan from 26 companies from 2016 to 2021. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Prakash Varadarajan been practicing?
Dr. Varadarajan graduated from medical school in 2003, 23 years ago.
Does Dr. Prakash Varadarajan do research?
Dmand AI links 3 publications to Dr. Varadarajan, published from 2011 to 2016. Dr. Varadarajan has worked on 1 clinical trial.
Who does Dr. Prakash Varadarajan publish with?
Dr. Varadarajan's most frequent co-authors are Athanassios Argiris, MD (1 shared paper), Ralph J. Deberardinis, MD, PhD (1 shared paper) and Yissela Analy Escobedo (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card